Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 4
1954 2
1955 1
1956 3
1957 2
1958 2
1959 3
1960 1
1973 4
1976 5
1978 2
1979 4
1981 1
1982 2
1983 3
1984 5
1985 2
1986 2
1987 1
1988 3
1989 1
1990 3
1991 2
1992 3
1993 5
1994 2
1995 1
1996 2
1997 1
1998 6
1999 5
2000 7
2001 4
2002 3
2003 2
2004 1
2005 8
2006 2
2007 6
2008 8
2009 8
2010 8
2011 8
2012 10
2013 17
2014 14
2015 16
2016 6
2017 18
2018 19
2019 17
2020 21
2021 16
2022 17
2023 23
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

337 results

Results by year

Filters applied: . Clear all
Page 1
Human African trypanosomiasis.
Büscher P, Cecchi G, Jamonneau V, Priotto G. Büscher P, et al. Among authors: cecchi g. Lancet. 2017 Nov 25;390(10110):2397-2409. doi: 10.1016/S0140-6736(17)31510-6. Epub 2017 Jun 30. Lancet. 2017. PMID: 28673422 Review.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Weller M, et al. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23. Lancet Oncol. 2017. PMID: 28844499 Free article. Clinical Trial.
Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a-b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery.
Henschke CI, Yip R, Sun Q, Li P, Kaufman A, Samstein R, Connery C, Kohman L, Lee P, Tannous H, Yankelevitz DF, Taioli E, Rosenzweig K, Flores RM; I-ELCAP; IELCART Investigators. Henschke CI, et al. J Thorac Oncol. 2024 Mar;19(3):476-490. doi: 10.1016/j.jtho.2023.10.002. Epub 2023 Oct 6. J Thorac Oncol. 2024. PMID: 37806384
Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?
Informal Expert Group on Gambiense HAT Reservoirs; Büscher P, Bart JM, Boelaert M, Bucheton B, Cecchi G, Chitnis N, Courtin D, Figueiredo LM, Franco JR, Grébaut P, Hasker E, Ilboudo H, Jamonneau V, Koffi M, Lejon V, MacLeod A, Masumu J, Matovu E, Mattioli R, Noyes H, Picado A, Rock KS, Rotureau B, Simo G, Thévenon S, Trindade S, Truc P, Van Reet N. Informal Expert Group on Gambiense HAT Reservoirs, et al. Among authors: cecchi g. Trends Parasitol. 2018 Mar;34(3):197-207. doi: 10.1016/j.pt.2017.11.008. Epub 2018 Jan 23. Trends Parasitol. 2018. PMID: 29396200 Free PMC article. Review.
Identifying Splitting Through Sentiment Analysis.
Colibazzi T, Abrami A, Stern B, Caligor E, Fertuck EA, Lubin M, Clarkin J, Cecchi G. Colibazzi T, et al. Among authors: cecchi g. J Pers Disord. 2023 Feb;37(1):36-48. doi: 10.1521/pedi.2023.37.1.36. J Pers Disord. 2023. PMID: 36723422
Developing a Progressive Control Pathway for African Animal Trypanosomosis.
Diall O, Cecchi G, Wanda G, Argilés-Herrero R, Vreysen MJB, Cattoli G, Viljoen GJ, Mattioli R, Bouyer J. Diall O, et al. Among authors: cecchi g. Trends Parasitol. 2017 Jul;33(7):499-509. doi: 10.1016/j.pt.2017.02.005. Epub 2017 Apr 26. Trends Parasitol. 2017. PMID: 28456474 Free article. Review.
Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines.
Baxi EG, Thompson T, Li J, Kaye JA, Lim RG, Wu J, Ramamoorthy D, Lima L, Vaibhav V, Matlock A, Frank A, Coyne AN, Landin B, Ornelas L, Mosmiller E, Thrower S, Farr SM, Panther L, Gomez E, Galvez E, Perez D, Meepe I, Lei S, Mandefro B, Trost H, Pinedo L, Banuelos MG, Liu C, Moran R, Garcia V, Workman M, Ho R, Wyman S, Roggenbuck J, Harms MB, Stocksdale J, Miramontes R, Wang K, Venkatraman V, Holewenski R, Sundararaman N, Pandey R, Manalo DM, Donde A, Huynh N, Adam M, Wassie BT, Vertudes E, Amirani N, Raja K, Thomas R, Hayes L, Lenail A, Cerezo A, Luppino S, Farrar A, Pothier L, Prina C, Morgan T, Jamil A, Heintzman S, Jockel-Balsarotti J, Karanja E, Markway J, McCallum M, Joslin B, Alibazoglu D, Kolb S, Ajroud-Driss S, Baloh R, Heitzman D, Miller T, Glass JD, Patel-Murray NL, Yu H, Sinani E, Vigneswaran P, Sherman AV, Ahmad O, Roy P, Beavers JC, Zeiler S, Krakauer JW, Agurto C, Cecchi G, Bellard M, Raghav Y, Sachs K, Ehrenberger T, Bruce E, Cudkowicz ME, Maragakis N, Norel R, Van Eyk JE, Finkbeiner S, Berry J, Sareen D, Thompson LM, Fraenkel E, Svendsen CN, Rothstein JD. Baxi EG, et al. Among authors: cecchi g. Nat Neurosci. 2022 Feb;25(2):226-237. doi: 10.1038/s41593-021-01006-0. Epub 2022 Feb 3. Nat Neurosci. 2022. PMID: 35115730 Free PMC article.
A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP).
Henschke CI, Yip R, Shaham D, Markowitz S, Cervera Deval J, Zulueta JJ, Seijo LM, Aylesworth C, Klingler K, Andaz S, Chin C, Smith JP, Taioli E, Altorki N, Flores RM, Yankelevitz DF; International Early Lung Cancer Action Program Investigators. Henschke CI, et al. Radiology. 2023 Nov;309(2):e231988. doi: 10.1148/radiol.231988. Radiology. 2023. PMID: 37934099
337 results